Skip to main content

Table 1 Recommendations in the related guidelines

From: Tranexamic acid and trauma-induced coagulopathy

Guidelines Year Committee Recommendation
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. 2013 The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis Trauma patients who present with severe bleeding, characterized by a marked hyperfibrinolytic state could be treated with antifibrinolytic agents (moderate quality).
A practical guideline for the hematological management of major haemorrhage. 2015 British Committee for Standards in Haematology Adult trauma patients with, or at risk of, major hemorrhage, should be given TXA as soon as possible after injury (grade 1A).
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. 2016 The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma TXA administration was recommended as early as possible to a trauma patient who is bleeding or at risk of significant hemorrhaging (grade 1A)
Consider administration of the first dose of TXA en route to the hospital (grade 2C)
Major trauma: assessment and initial management. 2016 National Clinical Guideline Centre Use intravenous TXA as soon as possible in patients with major trauma and active or suspected active bleeding.
Do not use intravenous TXA more than 3 h after injury in patients with major trauma unless there is evidence of hyperfibrinolysis.
  1. DIC disseminated intravascular coagulation, TXA tranexamic acid